Hiring Freeze Will Affect FDA Commissioner, ORM Director Appointments
This article was originally published in The Tan Sheet
Executive Summary
Acting FDA Commissioner Bernard Schwetz, PhD, will continue to make funding the agency's science base a top priority, he stresses in a Jan. 22 email to agency staff.